ASP Isotopes Inc.

Analysis for Ticker: ASPI

ASP Isotopes Inc operates as a development stage materials company that claims to enrich isotopes for nuclear medicine, semiconductors, and green energy fuels at a facility in Pretoria South Africa. The business tells a story of high technology, but the math reveals a company that produces zero commercial isotopes while extracting 320,3$ million from the public in one year. It is like a company that promises to build a rocket but spends all its time selling pieces of the rocket to neighbors to pay for the pilots' expensive suits. With an accumulated deficit of 231,2$ million and a net loss of 159,8$ million in 2025, the enterprise is incinerating cash while the people running it take millions in free shares. The current math is a disaster because the company burns through cash much faster than it can ever hope to earn it, requiring a constant stream of new investors to pay for the previous ones. The mechanism for this wealth transfer began on 15/11/2022, when founder Paul Elliot Mann received 500.000 restricted shares for free and officer Robert Ainscow received 600.000 shares. Giving away shares for free is like a lemonade stand giving its owners extra cups for nothing, which makes the cups held by other people worth less. In 2023, the auditing firm EisnerAmper LLP billed 357.000$ to watch the books. Entering 2024, the company had 48,9 million shares outstanding, but lacking cash, its subsidiary Quantum Leap Energy issued 25,9$ million in convertible notes in 03/2024 and 06/2024. This toxic debt is like borrowing one toy from a friend but agreeing to give back two toys later, even if you do not have any, because the notes convert into shares at a 20,0% discount to the market price.